fda compounding semaglutide news september 2025 Why the Issued 30 Warning Letters to Telehealth Sites Marketing Compounded GLP-1s FDA and Novo Nordisk Warned

If stored incorrectly, such as being exposed to extreme heat, freezing temperatures, or light, Ozempic may lose its potency

In the SURMOUNT-1 clinical trial, individuals with overweight/obesity without diabetes taking tirzepatide (5 mg, 10 mg, and 15 mg once weekly) lost 16%, 21.4%, and 22.5% of body weight, respectively, after 72 weeks

Postpartum iron depletion is common, and reduced food intake on GLP-1 can worsen it

Available from: Isaacs J, Gonalves J, Strohal R, Castaeda-Hernndez G, Azevedo V, Drner T, et al

tirzepatide (Zepbound) Key differences: Retatrutide adds glucagon receptor activity Slightly greater weight loss potential Similar side effect profiles Similar titration approach For comprehensive weight loss peptide comparisons, see our best peptides for weight loss guide

The loss of weight continued through end of treatment period